---
title: "ResMed Inc. Stock Falls Wednesday, Underperforms Market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293521176.md"
description: "ResMed Inc. (RMD) shares fell 1.48% to $192.91 on Wednesday, underperforming the broader market as the S&P 500 and Dow Jones also declined. This marks the stock's fourth consecutive day of losses, with ResMed now trading 34.34% below its 52-week high of $293.81 set in August. Trading volume remained significantly below the 50-day average."
datetime: "2026-07-22T20:58:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293521176.md)
  - [en](https://longbridge.com/en/news/293521176.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293521176.md)
generator: "portal-rs"
---

# ResMed Inc. Stock Falls Wednesday, Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of ResMed Inc. (RMD) slipped 1.48% to $192.91 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.14% to 7,498.96 and Dow Jones Industrial Average falling 0.01% to 52,218.58.

This was the stock's fourth consecutive day of losses.

ResMed Inc. closed 34.34% below its 52-week high of $293.81, which the company achieved on August 22nd.

Trading volume (970,954) remained 575,318 below its 50-day average volume of 1.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 22, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-22-26 1658ET

### Related Stocks

- [RMD.US](https://longbridge.com/en/quote/RMD.US.md)
- [RMD.AU](https://longbridge.com/en/quote/RMD.AU.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Empowered Funds LLC Buys New Shares in ResMed Inc. $RMD](https://longbridge.com/en/news/297397397.md)
- [Morgan Stanley Remains a Buy on Integral Diagnostics Ltd. (IDX)](https://longbridge.com/en/news/297468614.md)
- [ResMed (RMD) Q4 2026 Earnings Call Transcript](https://longbridge.com/en/news/295950697.md)
- [ResMed beats on earnings and ups dividend, yet shares plummet](https://longbridge.com/en/news/295180735.md)
- [ResMed CEO Michael J. Farrell reports disposal of 4,991 common shares worth $1,026,594.05](https://longbridge.com/en/news/295521442.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**